British drugs giant GSK is seeking to speed up drugs discovery by establishing a customised laboratory with Syngene International. The company has signed an agreement for the construction of a new facility in South Africa and will be able to start operations there next year.
British drugs giant GSK is seeking to speed up drugs discovery by establishing a customised laboratory with Syngene International. The contract research arm of Indian pharmaceutical firm Biocon offers discovery, development and manufacturing services to the pharmaceutical and biotechnology industries.